Home › Immunoglobulin Light-chain Amyloidosis › Minnesota
Immunoglobulin Light-chain Amyloidosis clinical trials in Minnesota
5 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Minnesota.
Cities in Minnesota
Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05898646SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07850284A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- GSK Investigational Site, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Mercy Hospital, Coon Rapids
- Fairview Southdale Hospital, Edina
- Abbott-Northwestern Hospital, Minneapolis
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.